Paolo Verdecchia
#98,151
Most Influential Person Now
Researcher
Paolo Verdecchia's AcademicInfluence.com Rankings
Paolo Verdecchiaengineering Degrees
Engineering
#2496
World Rank
#3422
Historical Rank
Biomedical Engineering
#65
World Rank
#66
Historical Rank
Applied Physics
#324
World Rank
#336
Historical Rank
Electrical Engineering
#455
World Rank
#506
Historical Rank
Download Badge
Engineering Physics
Paolo Verdecchia's Degrees
- Masters Electrical Engineering University of Milan
- Bachelors Physics University of Florence
Why Is Paolo Verdecchia Influential?
(Suggest an Edit or Addition)Paolo Verdecchia's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement (2003) (1756)
- Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. (1994) (1724)
- Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. (1990) (1268)
- European Society of Hypertension position paper on ambulatory blood pressure monitoring. (2013) (1184)
- Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients (2001) (1135)
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (2020) (905)
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (2020) (905)
- Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. (2005) (736)
- European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. (2014) (731)
- Prognostic significance of serial changes in left ventricular mass in essential hypertension. (1998) (636)
- Prognostic value of ambulatory blood pressure : current evidence and clinical implications. (2000) (627)
- Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study (2000) (523)
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects (2004) (506)
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects (2004) (506)
- Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. (1995) (433)
- Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. (1998) (420)
- Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial (2009) (390)
- Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial (2009) (390)
- Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. (2001) (369)
- Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study (2009) (348)
- Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. (2000) (341)
- Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (2005) (340)
- Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention (2005) (340)
- Atrial Fibrillation in Hypertension: Predictors and Outcome (2003) (313)
- Atrial Fibrillation in Hypertension: Predictors and Outcome (2003) (313)
- Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. (2003) (308)
- Short- and Long-Term Incidence of Stroke in White-Coat Hypertension (2005) (308)
- Short- and Long-Term Incidence of Stroke in White-Coat Hypertension (2005) (308)
- Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. (2003) (308)
- Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. (1993) (302)
- Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension (2001) (290)
- Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. (2016) (290)
- Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients (2011) (281)
- Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients (2011) (281)
- Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. (2002) (270)
- Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. (1998) (269)
- Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications (2012) (262)
- Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications (2012) (262)
- Improved electrocardiographic diagnosis of left ventricular hypertrophy. (1994) (249)
- Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. (1996) (223)
- Different Prognostic Impact of 24-Hour Mean Blood Pressure and Pulse Pressure on Stroke and Coronary Artery Disease in Essential Hypertension (2001) (217)
- Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13 844 patients with hypertension (2014) (206)
- Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). (2008) (202)
- White coat hypertension and white coat effect. Similarities and differences. (1995) (201)
- Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension. (1992) (194)
- Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. (1999) (194)
- Task Force II: Blood pressure measurement and cardiovacular outcome (2001) (186)
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
- Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study (2002) (174)
- High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. (2001) (172)
- Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. (2007) (172)
- Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. (2007) (172)
- Dippers versus non-dippers. (1991) (164)
- Clinical value of ambulatory blood pressure: evidence and limits. (2015) (157)
- Prognostic value of 24-hour blood pressure in pregnancy. (1999) (156)
- Added Predictive Value of Night-Time Blood Pressure Variability for Cardiovascular Events and Mortality: The Ambulatory Blood Pressure–International Study (2014) (152)
- Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension (1995) (149)
- Task force V: White-coat hypertension (1999) (148)
- Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database (1994) (146)
- Blood Pressure Monitoring. Task force V: White-coat hypertension. (1999) (140)
- Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) (2011) (136)
- Prognostic significance of the white coat effect. (1997) (134)
- Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions – Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability (2016) (132)
- Ambulatory Blood Pressure and Cardiovascular Outcome in Relation to Perceived Sleep Deprivation (2007) (128)
- Ambulatory Blood Pressure and Cardiovascular Outcome in Relation to Perceived Sleep Deprivation (2007) (128)
- Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. (2002) (126)
- Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. (2002) (126)
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis (2008) (124)
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis (2008) (124)
- Association Between Periodontal Disease and Left Ventricle Mass in Essential Hypertension (2003) (118)
- Association Between Periodontal Disease and Left Ventricle Mass in Essential Hypertension (2003) (118)
- Age and Blood Pressure Changes A 20‐Year Follow‐up Study in Nuns in a Secluded Order (1988) (116)
- Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies (2018) (115)
- Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies (2018) (115)
- Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years (2019) (112)
- Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension (1992) (111)
- Electrocardiographic features of patients with COVID-19 pneumonia (2020) (111)
- Electrocardiographic features of patients with COVID-19 pneumonia (2020) (111)
- Independent predictors of isolated clinic (`white-coat') hypertension (2001) (111)
- Gender, day-night blood pressure changes, and left ventricular mass in essential hypertension. Dippers and peakers. (1995) (107)
- Properly defining white coat hypertension. (2002) (103)
- Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. (2004) (102)
- Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. (2004) (102)
- Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. (2000) (94)
- The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction (2008) (93)
- The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction (2008) (93)
- Prevalence and determinants of left ventricular diastolic filling abnormalities in an unselected hypertensive population. (1990) (93)
- Masked hypertension: evaluation, prognosis, and treatment. (2010) (92)
- Masked hypertension: evaluation, prognosis, and treatment. (2010) (92)
- Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. (1996) (87)
- Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. (1999) (87)
- When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. (2003) (86)
- Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies. (1999) (85)
- Early cardiac changes after menopause. (1998) (82)
- Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension (1998) (82)
- Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? (2007) (79)
- Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive PatientsNovelty and Significance (2016) (79)
- Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? (2007) (79)
- Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. (2008) (76)
- Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. (2008) (76)
- Quantitative assessment of day-to-day spontaneous variability in non-invasive ambulatory blood pressure measurements in essential hypertension. (1991) (75)
- Task Force III: Target-organ damage, morbidity and mortality (1999) (74)
- Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. (2006) (73)
- Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. (2006) (73)
- Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials (2010) (72)
- Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials (2010) (72)
- Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension (1996) (72)
- Risk stratification of left ventricular hypertrophy in systemic hypertension using noninvasive ambulatory blood pressure monitoring. (1990) (70)
- Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project (2020) (69)
- Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study. (2013) (68)
- SARS-CoV-2 vaccines: Lights and shadows (2021) (67)
- SARS-CoV-2 vaccines: Lights and shadows (2021) (67)
- Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention (2010) (67)
- Do angiotensin II receptor blockers increase the risk of myocardial infarction? (2005) (66)
- Improved cardiovascular risk stratification by a simple ECG index in hypertension. (2003) (66)
- Do angiotensin II receptor blockers increase the risk of myocardial infarction? (2005) (66)
- Improved cardiovascular risk stratification by a simple ECG index in hypertension. (2003) (66)
- Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value (2005) (65)
- Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value (2005) (65)
- Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring (2009) (64)
- Natural history of hypertension subtypes. (2005) (64)
- Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring (2009) (64)
- Natural history of hypertension subtypes. (2005) (64)
- Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease (2015) (64)
- Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease (2015) (64)
- Asymmetric left ventricular remodeling due to isolated septal thickening in patients with systemic hypertension and normal left ventricular masses. (1994) (62)
- Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. (2005) (61)
- Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
- Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment. (1983) (60)
- High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension (2001) (59)
- The clinical significance of white-coat and masked hypertension (2007) (58)
- Ambulatory Blood Pressure for Cardiovascular Risk Stratification (2007) (58)
- Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) (2012) (58)
- Ambulatory Blood Pressure for Cardiovascular Risk Stratification (2007) (58)
- White-coat hypertension (1995) (58)
- Hypertension and microalbuminuria: the new detrimental duo (2004) (58)
- The clinical significance of white-coat and masked hypertension (2007) (58)
- Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis (2012) (56)
- Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension (2002) (56)
- Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes. (2018) (56)
- Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis (2012) (56)
- The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy (2009) (55)
- The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy (2009) (55)
- Lack of association between blood pressure variability and left ventricular mass in essential hypertension. (1998) (55)
- Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications (2015) (53)
- [The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the weapons are ready]. (2003) (53)
- [The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the weapons are ready]. (2003) (53)
- Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications (2015) (53)
- Diuretic Treatment of Hypertension (2011) (52)
- Diuretic Treatment of Hypertension (2011) (52)
- White-coat hypertension in adults (2005) (51)
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studie (2012) (51)
- White-coat hypertension in adults (2005) (51)
- Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument (2014) (50)
- Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension (2007) (50)
- Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument (2014) (50)
- Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials (2009) (50)
- Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials (2009) (50)
- The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease (2012) (49)
- Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. (2007) (49)
- Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. (2007) (49)
- More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis. (2016) (45)
- Echocardiography in arterial hypertension: when, why and how? (1994) (45)
- Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin–angiotensin system blockers (2012) (45)
- Prognostic Value of Ambulatory Blood Pressure (2000) (45)
- More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis. (2016) (45)
- Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin–angiotensin system blockers (2012) (45)
- Why switch from warfarin to NOACs? (2016) (44)
- Why switch from warfarin to NOACs? (2016) (44)
- Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study (2019) (42)
- Early invasive versus selectively invasive strategy in patients with non‐ST‐segment elevation acute coronary syndrome: Impact of age (2014) (40)
- New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. (2010) (40)
- Short-and Long-Term Incidence of Stroke in WhiteCoat Hypertension (2005) (40)
- New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis. (2010) (40)
- Early invasive versus selectively invasive strategy in patients with non‐ST‐segment elevation acute coronary syndrome: Impact of age (2014) (40)
- Short-and Long-Term Incidence of Stroke in WhiteCoat Hypertension (2005) (40)
- β-Blockers Reduce Mortality in Patients Undergoing High-Risk Non-Cardiac Surgery (2010) (39)
- Plasma norepinephrine and left ventricular hypertrophy in systemic hypertension. (1984) (39)
- β-Blockers Reduce Mortality in Patients Undergoing High-Risk Non-Cardiac Surgery (2010) (39)
- Reference values for ambulatory blood pressure and self-measured blood pressure based on prospective outcome data (2001) (37)
- Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials (2009) (37)
- Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study. (2000) (37)
- Hypertension, inflammation and atrial fibrillation. (2014) (36)
- Hypertension, inflammation and atrial fibrillation. (2014) (36)
- Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension. (1982) (35)
- Infanticide in brown bear: A case-study in the Italian Alps - Genetic identification of perpetrator and implications in small populations (2018) (35)
- Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? (2004) (35)
- Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? (2004) (35)
- Tight Versus Standard Blood Pressure Control in Patients With Hypertension With and Without Cardiovascular Disease (2014) (34)
- Left Ventricular Hypertrophy and Obesity: Only a Matter of Fat? (2015) (34)
- Use of ambulatory blood pressure measurement in the definition of resistant hypertension: a review of the evidence (2014) (34)
- Tight Versus Standard Blood Pressure Control in Patients With Hypertension With and Without Cardiovascular Disease (2014) (34)
- Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study. (2010) (33)
- The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. (2020) (33)
- Estimate of white-coat effect and arterial stiffness (2007) (33)
- The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. (2020) (33)
- Estimate of white-coat effect and arterial stiffness (2007) (33)
- Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group. (1992) (33)
- [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. (2020) (32)
- Clinical usefulness of ambulatory blood pressure monitoring. (2004) (32)
- COVID-19 (2020) (32)
- COVID-19 (2020) (32)
- [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. (2020) (32)
- Converting enzyme inhibition vs diuretic therapy as first therapeutic approach to the elderly hypertensive patient (1984) (32)
- Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris. (1993) (32)
- Clinical usefulness of ambulatory blood pressure monitoring. (2004) (32)
- Sudden Cardiac Death in Hypertensive Patients (2019) (31)
- Clinical relevance of office underestimation of usual blood pressure in treated hypertension. (1999) (31)
- Sudden Cardiac Death in Hypertensive Patients (2019) (31)
- Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. (2002) (31)
- Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol. (1984) (30)
- How can we use the results of ambulatory blood pressure monitoring in clinical practice? (2005) (30)
- Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study (2011) (30)
- How can we use the results of ambulatory blood pressure monitoring in clinical practice? (2005) (30)
- Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement. (2014) (29)
- Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension. (2014) (29)
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later (2021) (29)
- Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension. (2014) (29)
- White-coat hypertension in adults and children. (1999) (29)
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later (2021) (29)
- Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. (2004) (29)
- Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension. (2004) (29)
- Aggressive blood pressure lowering is dangerous: the J-curve: con side of the arguement. (2014) (29)
- Prediction of strokes versus cardiac events by ambulatory monitoring of blood pressure: results from an international database (2007) (27)
- Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study. (2018) (27)
- Aliskiren versus ramipril in hypertension (2010) (26)
- Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients (2017) (26)
- Aliskiren versus ramipril in hypertension (2010) (26)
- More Versus Less Intensive Blood Pressure–Lowering StrategyNovelty and Significance (2016) (26)
- Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine (2021) (26)
- Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes (2012) (26)
- New-onset diabetes in treated hypertensive patients (2005) (26)
- New-onset diabetes in treated hypertensive patients (2005) (26)
- Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine (2021) (26)
- More Versus Less Intensive Blood Pressure–Lowering StrategyNovelty and Significance (2016) (26)
- Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes (2012) (26)
- Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation. (2017) (26)
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus (2020) (25)
- Noninvasive assessment of chronotropic and inotropic response to preferential beta‐1 and beta‐2 adrenoceptor stimulation (1984) (25)
- Prognostic value of midwall shortening fraction and its relation with left ventricular mass in systemic hypertension. (2001) (25)
- Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
- Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project (2021) (25)
- Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure (2004) (25)
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus (2020) (25)
- Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure (2004) (25)
- Microalbuminuria and hypertension. (2005) (24)
- Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. (2012) (24)
- Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement (2006) (24)
- Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients (2006) (24)
- Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. (2012) (24)
- Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons (2014) (24)
- Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement (2006) (24)
- Microalbuminuria and hypertension. (2005) (24)
- Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons (2014) (24)
- Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study (2020) (24)
- Neutrophil count and ambulatory pulse pressure as predictors of cardiovascular adverse events in postmenopausal women with hypertension. (2011) (23)
- Is the definition of daytime and nighttime blood pressure prognostically relevant? (2008) (23)
- Statins in acute coronary syndrome: very early initiation and benefits (2012) (23)
- New-onset diabetes, antihypertensive treatment, and outcome. (2007) (23)
- Left ventricular mass and systolic dysfunction in essential hypertension (2002) (23)
- Neutrophil count and ambulatory pulse pressure as predictors of cardiovascular adverse events in postmenopausal women with hypertension. (2011) (23)
- Statins in acute coronary syndrome: very early initiation and benefits (2012) (23)
- Is the definition of daytime and nighttime blood pressure prognostically relevant? (2008) (23)
- New-onset diabetes, antihypertensive treatment, and outcome. (2007) (23)
- Clinical impact of various geometric models for calculation of echocardiographic left ventricular mass (1998) (22)
- Are Observational Studies More Informative Than Randomized Controlled Trials in Hypertension?: Pro Side of the Argument (2013) (22)
- Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients. (2004) (22)
- Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients. (2004) (22)
- Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach (2015) (21)
- Association of Extreme Nocturnal Dipping With Cardiovascular Events Strongly Depends on Age (2019) (21)
- Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain (2018) (21)
- Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain (2018) (21)
- The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk (2021) (21)
- Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach (2015) (21)
- Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both. (2004) (21)
- Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both. (2004) (21)
- Telmisartan for the reduction of cardiovascular morbidity and mortality (2011) (21)
- Telmisartan for the reduction of cardiovascular morbidity and mortality (2011) (21)
- Hypertensive disorders during pregnancy: clinical applicability of risk prediction models. (2011) (20)
- Defining normal ambulatory blood pressure in relation to target organ damage and prognosis. (1993) (20)
- Hypertensive disorders during pregnancy: clinical applicability of risk prediction models. (2011) (20)
- Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure. (2000) (20)
- Prognostic impact of sex–ambulatory blood pressure interactions in 10 cohorts of 17 312 patients diagnosed with hypertension: systematic review and meta-analysis (2015) (20)
- Masked tachycardia. A predictor of adverse outcome in hypertension (2017) (20)
- Clinical utility of ambulatory blood pressure monitoring in the management of hypertension (2014) (20)
- Clinical utility of ambulatory blood pressure monitoring in the management of hypertension (2014) (20)
- Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension (2013) (19)
- Hypertension and the J-curve phenomenon: implications for tight blood pressure control (2013) (19)
- European and US guidelines for arterial hypertension: similarities and differences. (2019) (19)
- Treatment strategies for osteoarthritis patients with pain and hypertension (2010) (19)
- European and US guidelines for arterial hypertension: similarities and differences. (2019) (19)
- Hypertension and the J-curve phenomenon: implications for tight blood pressure control (2013) (19)
- Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension (2013) (19)
- Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus (2011) (19)
- Treatment strategies for osteoarthritis patients with pain and hypertension (2010) (19)
- Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy (2011) (19)
- Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy (2011) (19)
- Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study. (2019) (19)
- Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus (2011) (19)
- The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. (2010) (19)
- A risk score for predicting 1-year mortality in patients ≥75 years of age presenting with non-ST-elevation acute coronary syndrome. (2015) (18)
- Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study (2011) (18)
- Non-invasive ambulatory BP monitoring during the night: randomised comparison of different reading intervals. (1994) (18)
- Comparative assessment of angiotensin receptor blockers in different clinical settings (2009) (18)
- A risk score for predicting 1-year mortality in patients ≥75 years of age presenting with non-ST-elevation acute coronary syndrome. (2015) (18)
- Comparative assessment of angiotensin receptor blockers in different clinical settings (2009) (18)
- Fixed-Dose Combination Therapy in Hypertension (2012) (17)
- The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study (2015) (17)
- Fixed-Dose Combination Therapy in Hypertension (2012) (17)
- Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study. (2013) (17)
- Association between endothelial dysfunction and major cardiovascular events in peripheral arterial disease. (2003) (17)
- Blood pressure changes over 20 years in nuns in a secluded order. (1985) (17)
- The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study (2015) (17)
- Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study (2020) (17)
- Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview (2012) (16)
- The 2014 hypertension guidelines: implications for patients and practitioners in Asia (2015) (16)
- Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension. (1991) (16)
- Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life. (2016) (16)
- The 2014 hypertension guidelines: implications for patients and practitioners in Asia (2015) (16)
- COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect" (2022) (16)
- COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect" (2022) (16)
- Knowing the new Omicron BA.2.75 variant (‘Centaurus’): A simulation study (2022) (16)
- Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview (2012) (16)
- Blood pressure lowering in the oldest old. (2010) (16)
- Knowing the new Omicron BA.2.75 variant (‘Centaurus’): A simulation study (2022) (16)
- Blood pressure lowering in the oldest old. (2010) (16)
- Compared With Whom?: Addressing the Prognostic Value of Ambulatory Blood Pressure Categories (2006) (15)
- Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study (2017) (15)
- Hypertension around the world: new insights from developing countries. (2013) (15)
- Prognostic value of circadian blood pressure changes in relation to differing measures of day and night. (2008) (15)
- Above which blood pressure level does the risk of atrial fibrillation increase? (2012) (15)
- Prognostic value of circadian blood pressure changes in relation to differing measures of day and night. (2008) (15)
- Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study (2019) (15)
- Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study (2017) (15)
- Hypertension around the world: new insights from developing countries. (2013) (15)
- Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus (2009) (15)
- Compared With Whom?: Addressing the Prognostic Value of Ambulatory Blood Pressure Categories (2006) (15)
- Above which blood pressure level does the risk of atrial fibrillation increase? (2012) (15)
- White-coat hypertension: a selection bias? (1999) (15)
- Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus (2009) (15)
- Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk (2010) (14)
- Prognostic value of serial changes in left ventricular mass in essential hypertension (1997) (14)
- Fixed-dose combination therapy in hypertension: cons. (2012) (14)
- Long‐term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case‐control study (2000) (14)
- Where Are We With the Management of Hypertension? From Science to Clinical Practice (2009) (14)
- Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome (2015) (14)
- Ambulatory monitoring for prediction of cardiac and cerebral events (2001) (14)
- Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy—From Pathophysiology to Practical Implications (2015) (14)
- Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy—From Pathophysiology to Practical Implications (2015) (14)
- Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk (2010) (14)
- Fixed-dose combination therapy in hypertension: cons. (2012) (14)
- Ageing, ACE2 deficiency and bad outcome in COVID-19 (2021) (13)
- Prognostic impact of clinic, daytime, and nighttime systolic blood pressure in 9 cohorts of 13,843 patients with hypertension: systematic review and meta-analysis (2014) (13)
- Efficacy of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris (1991) (13)
- Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension (2003) (13)
- Ageing, ACE2 deficiency and bad outcome in COVID-19 (2021) (13)
- Does brachial pulse pressure predict coronary events? (2007) (13)
- The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? (2018) (13)
- Does brachial pulse pressure predict coronary events? (2007) (13)
- Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study). (2014) (13)
- The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? (2018) (13)
- Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension (2003) (13)
- Arterial Hypertension and Cardiac Damage (2008) (13)
- [The day-night changes in ambulatory blood pressure: another risk indicator in hypertension?]. (1992) (13)
- Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19 (2021) (12)
- Managing hypertension in 2018: which guideline to follow? (2019) (12)
- SARS-CoV-2 infection and ACE2 inhibition. (2021) (12)
- Managing hypertension in 2018: which guideline to follow? (2019) (12)
- Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry (2022) (12)
- Statistical guidelines for contributors to medical journals (1983) (12)
- Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial (2019) (12)
- Multivariable Analysis in Cerebrovascular Research: Practical Notes for the Clinician (2013) (12)
- Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19 (2021) (12)
- Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial (2019) (12)
- SARS-CoV-2 infection and ACE2 inhibition. (2021) (12)
- Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina. (1989) (12)
- Using out of office blood pressure monitoring in the management of hypertension (2001) (12)
- Multivariable Analysis in Cerebrovascular Research: Practical Notes for the Clinician (2013) (12)
- Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry (2022) (12)
- Predictors of in-hospital and long-term mortality in unselected patients admitted to a modern coronary care unit (2019) (11)
- Optimal Use of the Non-Inferiority Trial Design (2020) (11)
- Very early initiation of statin therapy and mortality in patients with acute coronary syndrome (2012) (11)
- Response to Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement (2009) (11)
- Ambulatory blood pressure and risk of cardiovascular disease in type II diabetes mellitus (1994) (11)
- Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together? (2010) (11)
- Reversal of Left Ventricular Hypertrophy (2004) (11)
- Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together? (2010) (11)
- The Optimal Blood Pressure Target for Patients with Coronary Artery Disease (2010) (11)
- Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension (2017) (11)
- Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (2010) (11)
- Very early initiation of statin therapy and mortality in patients with acute coronary syndrome (2012) (11)
- Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population (2008) (11)
- Low-dose captopril therapy in mild and moderate hypertension. Randomized comparison of twice daily vs three times daily doses. (1983) (11)
- The Optimal Blood Pressure Target for Patients with Coronary Artery Disease (2010) (11)
- Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension (2017) (11)
- Methods of measurements: home and ambulatory blood pressure monitoring. (2010) (11)
- Response to Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement (2009) (11)
- Atrial Activation Analysis by Surface P Wave and Multipolar Esophageal Recording After Cardioversion of Persistent Atrial Fibrillation (2003) (11)
- Optimal Use of the Non-Inferiority Trial Design (2020) (11)
- Reversal of Left Ventricular Hypertrophy (2004) (11)
- Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population (2008) (11)
- Angiotensin receptor blockers in hypertension. New insights from Japan (2010) (10)
- At the beginning of stiffening: endothelial dysfunction meets "pulsology". (2006) (10)
- Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects: 2.13 (2005) (10)
- Angiotensin receptor blockers in hypertension. New insights from Japan (2010) (10)
- Microcirculation and left-ventricular hypertrophy. (2012) (10)
- Interpretation of ambulatory blood pressure profile: a prognostic approach for clinical practice. (2015) (10)
- RAAS Inhibitors and Risk of Covid-19. (2020) (10)
- Keep Blood Pressure Low, but Not Too Much…. (2018) (10)
- Severity of COVID-19: The importance of being hypertensive. (2020) (10)
- Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis (2022) (10)
- At the beginning of stiffening: endothelial dysfunction meets "pulsology". (2006) (10)
- Regression of Left Ventricular Hypertrophy and Prevention of Stroke in Hypertensive Subjects: 2.13 (2005) (10)
- Microcirculation and left-ventricular hypertrophy. (2012) (10)
- Interpretation of ambulatory blood pressure profile: a prognostic approach for clinical practice. (2015) (10)
- RAAS Inhibitors and Risk of Covid-19. (2020) (10)
- Keep Blood Pressure Low, but Not Too Much…. (2018) (10)
- Severity of COVID-19: The importance of being hypertensive. (2020) (10)
- SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL (2009) (10)
- Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis (2022) (10)
- Efficacy and safety profile of aliskiren: practical implications for clinicians. (2014) (9)
- "The lower the BP the better" paradigm in the elderly: vanished by VALISH? (2010) (9)
- Does Malaria Cause Hypertension? (2016) (9)
- Blood pressure lowering in diabetic patients. (2012) (9)
- Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study. (1983) (9)
- Prognostic value of lipoprotein fractions in essential hypertension (2004) (9)
- Perioperative β blockade: the debate continues (2009) (9)
- Does Malaria Cause Hypertension? (2016) (9)
- Prognostic value of lipoprotein fractions in essential hypertension (2004) (9)
- Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study (2019) (9)
- "The lower the BP the better" paradigm in the elderly: vanished by VALISH? (2010) (9)
- Hypertensive urgencies and emergencies: Misconceptions and pitfalls. (2019) (9)
- Blood pressure lowering in diabetic patients. (2012) (9)
- Perioperative β blockade: the debate continues (2009) (9)
- Efficacy and safety profile of aliskiren: practical implications for clinicians. (2014) (9)
- Hypertensive urgencies and emergencies: Misconceptions and pitfalls. (2019) (9)
- Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. (2019) (8)
- The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study (2021) (8)
- Interpretation of ambulatory blood pressure profile for risk stratification: keep it simple. (2014) (8)
- Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension (2021) (8)
- [Hypertension after COVID-19 vaccination]. (2022) (8)
- Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients (2017) (8)
- Prognostic Value of Ambulatory Blood Pressure in the Obese: The Ambulatory Blood Pressure‐International Study (2016) (8)
- Pre-Clinical and Clinical Experience of Telmisartan in Cardiac Remodelling (2005) (8)
- Is the Development of Diabetes With Antihypertensive Therapy a Problem?—Pro (2006) (8)
- Duration of the antihypertensive action of atenolol, enalapril and placebo: a randomized within-patient study using ambulatory blood pressure monitoring. (1988) (8)
- Is the Development of Diabetes With Antihypertensive Therapy a Problem?—Pro (2006) (8)
- Left ventricular mass in dippers and non-dippers. (1995) (8)
- Interpretation of ambulatory blood pressure profile for risk stratification: keep it simple. (2014) (8)
- Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis. (2017) (8)
- Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study (2021) (8)
- Electrocardiographic changes in hypertensive disorders of pregnancy (2014) (8)
- Systolic and Diastolic Blood Pressure and Cardiovascular Outcomes. (2019) (8)
- [Hypertension after COVID-19 vaccination]. (2022) (8)
- Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension (2021) (8)
- Electrocardiographic changes in hypertensive disorders of pregnancy (2014) (8)
- Optimizing assessment of carotid and femoral intima-media thickness in essential hypertension. (2000) (8)
- "From apennines to andes:" does body mass index affect the relationship between age and blood pressure? (2012) (8)
- White-coat hypertension. (1996) (8)
- "From apennines to andes:" does body mass index affect the relationship between age and blood pressure? (2012) (8)
- Reversal of left ventricular hypertrophy: what have recent trials taught us? (2004) (7)
- Reducing blood pressure in people of different ages (2008) (7)
- Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients (2021) (7)
- PLASMA POTASSIUM DURING EXERCISE (1981) (7)
- Advances in the Treatment Strategies in Hypertension: Present and Future (2022) (7)
- Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project. (2022) (7)
- Echocardiography in Low‐Risk Hypertensive Patients (2019) (7)
- Modernization and hypertension: is the link changing? (2013) (7)
- Echocardiography in Low‐Risk Hypertensive Patients (2019) (7)
- Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project. (2022) (7)
- Reversal of left ventricular hypertrophy: what have recent trials taught us? (2004) (7)
- Ambulatory blood pressure monitoring in the elderly: features and perspectives. (2014) (7)
- Value of a simple echocardiographic linear predictor of left ventricular mass in systemic hypertension. (1999) (7)
- Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment (2011) (7)
- [Management of ST-elevation myocardial infarction in the Umbria region: results from the observational prospective Umbria-STEMI registry]. (2010) (7)
- Blood pressure increase during hospitalization for COVID-19 (2022) (7)
- Modernization and hypertension: is the link changing? (2013) (7)
- Ambulatory blood pressure monitoring in the elderly: features and perspectives. (2014) (7)
- Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations (2021) (7)
- Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients (2021) (7)
- Original articles prognostic value of combined echocardiography and ambulatory blood pressure monitoring in hypertensive patients at low or medium cardiovascular risk. (2001) (7)
- Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations (2021) (7)
- Blood pressure increase during hospitalization for COVID-19 (2022) (7)
- Twenty-four hour ambulatory blood pressure monitoring to all? Comments to the US Preventive Services Task Force document. (2015) (7)
- Advances in the Treatment Strategies in Hypertension: Present and Future (2022) (7)
- [Management of ST-elevation myocardial infarction in the Umbria region: results from the observational prospective Umbria-STEMI registry]. (2010) (7)
- Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment (2011) (7)
- Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy (2020) (7)
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
- Twenty-four hour ambulatory blood pressure monitoring to all? Comments to the US Preventive Services Task Force document. (2015) (7)
- Heart failure, pulse pressure and heart rate: Refining risk stratification. (2018) (6)
- The SPRINT trial. (2015) (6)
- Fragmented QRS as an early predictor of left ventricular systolic dysfunction in healthy individuals: a nested case-control study in the era of speckle tracking echocardiography (2020) (6)
- β-blockers and risk of all-cause mortality in non-cardiac surgery (2010) (6)
- Blood pressure variability and risk of stroke in chronic kidney disease. (2020) (6)
- Device-Pocket Hematoma after Cardiac Implantable Electronic Devices. (2020) (6)
- Blood pressure rise and ischaemic stroke (1995) (6)
- Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial (2012) (6)
- The natural history of white-coat hypertension in the long term. (2005) (6)
- Modern treatment of patients at risk: still a HOPE for ACE inhibitors? (2011) (6)
- Hyperglycemia During Acute Coronary Syndrome: Prognostic Implications (2016) (6)
- Heart failure, pulse pressure and heart rate: Refining risk stratification. (2018) (6)
- The natural history of white-coat hypertension in the long term. (2005) (6)
- The SPRINT trial. (2015) (6)
- Catheter ablation of atrial tachycardias after mitral valve surgery: A systematic review and meta‐analysis (2020) (6)
- Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man. (1984) (6)
- Modern treatment of patients at risk: still a HOPE for ACE inhibitors? (2011) (6)
- Electrocardiographic abnormalities of left ventricular repolarization: prognostic implications in hypertensive post-menopausal women. (2010) (6)
- Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. (2003) (6)
- Safety of dabigatran in an elderly population: single center experience in Italy. (2014) (6)
- Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. (2003) (6)
- β-blockers and risk of all-cause mortality in non-cardiac surgery (2010) (6)
- Intensive cardiac care unit admission trends during the COVID-19 outbreak in Italy: a multi-center study (2021) (6)
- Device-Pocket Hematoma after Cardiac Implantable Electronic Devices. (2020) (6)
- Hyperglycemia During Acute Coronary Syndrome: Prognostic Implications (2016) (6)
- order Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded (2007) (6)
- Electrocardiographic abnormalities of left ventricular repolarization: prognostic implications in hypertensive post-menopausal women. (2010) (6)
- Validation of the A&D wrist-cuff UB-511 (UB-512) device for self-measurement of blood pressure (2006) (6)
- Does echocardiography overestimate left ventricular mass? (1997) (6)
- Blood pressure variability and risk of stroke in chronic kidney disease. (2020) (6)
- Intensive blood pressure control in obese diabetic patients: clinical relevance of stroke prevention in the ACCORD trial (2012) (6)
- Validation of the A&D wrist-cuff UB-511 (UB-512) device for self-measurement of blood pressure (2006) (6)
- Safety of dabigatran in an elderly population: single center experience in Italy. (2014) (6)
- How Low Should We Go With Blood Pressure? (2017) (5)
- Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry (2019) (5)
- 7A.01: INCREASED RISK OF MORTALITY IN OBESE PATIENTS WITH HIGH NOCTURNAL BLOOD PRESSURE VARIABILITY. RESULTS FROM THE ABP-INTERNATIONAL STUDY (2015) (5)
- Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? (2018) (5)
- Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention. (2015) (5)
- Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry (2019) (5)
- Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation. (2020) (5)
- ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives (2017) (5)
- Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention. (2015) (5)
- Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet? (2018) (5)
- Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease (2018) (5)
- Influence of cigarette smoking on the electrocardiographic diagnosis of left ventricular hypertrophy in arterial hypertension. (1999) (5)
- PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives (2018) (5)
- PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives (2018) (5)
- Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients (2022) (5)
- Home ambulatory blood pressure readings do not differ from clinic readings taken at the same time of day. (1988) (5)
- An international database of prospective ambulatory blood pressure monitoring studies. (2003) (5)
- J-shaped relation between blood pressure and stroke. (2000) (5)
- Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis. (2022) (5)
- How Low Should We Go With Blood Pressure? (2017) (5)
- Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease (2018) (5)
- Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation. (2020) (5)
- [ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants]. (2013) (5)
- Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients (2022) (5)
- Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis. (2022) (5)
- Persistence of increased left ventricular mass despite optimal blood pressure control in hypertension. (2000) (4)
- Combined Use of Electrocardiography and Ultrasound to Detect Cardiac and Pulmonary Involvement after Recovery from COVID-19 Pneumonia: A Case Series (2021) (4)
- Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study. (2008) (4)
- The Tale of an Innocent: Intensive Treatment and the J-Curve in the SPRINT Trial (Systolic Blood Pressure Intervention Trial) (2017) (4)
- Electrocardiography for left ventricular hypertrophy in hypertension: time for re-evaluation? (1998) (4)
- Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk. (2014) (4)
- Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension (1989) (4)
- Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? (2008) (4)
- Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study. (2008) (4)
- Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study (2018) (4)
- Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol (2006) (4)
- Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study (2018) (4)
- Treatment strategies for isolated systolic hypertension in elderly patients (2020) (4)
- The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluation (2022) (4)
- Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
- Combined Use of Electrocardiography and Ultrasound to Detect Cardiac and Pulmonary Involvement after Recovery from COVID-19 Pneumonia: A Case Series (2021) (4)
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke (2008) (4)
- The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluation (2022) (4)
- The Tale of an Innocent: Intensive Treatment and the J-Curve in the SPRINT Trial (Systolic Blood Pressure Intervention Trial) (2017) (4)
- Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? (2008) (4)
- Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol (2006) (4)
- Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines (2022) (4)
- Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines (2022) (4)
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke (2008) (4)
- Treatment strategies for isolated systolic hypertension in elderly patients (2020) (4)
- High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. (2021) (4)
- Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project (2021) (4)
- High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. (2021) (4)
- [Hypertensive heart disease: diagnostic and therapeutic guidelines]. (2008) (4)
- More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension (2011) (3)
- Echocardiographic left ventricular hypertrophy: implications for clinicians. (2012) (3)
- Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-hour blood pressure in young hypertensive subjects. (2022) (3)
- [Arterial hypertension and heart diseases. Diagnostic-therapeutic guidelines. Joint Commission of the National Association of Hospital Cardiologists, the Italian Society of Cardiology and the Italian Society of Arterial Hypertension]. (1999) (3)
- Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective. (2008) (3)
- Echocardiographic left ventricular hypertrophy: implications for clinicians. (2012) (3)
- Gathering evidence on the prognostic role of central blood pressure in hypertension (2018) (3)
- Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study (2021) (3)
- 5 Ambulatory blood pressure monitoring in normotensive and hypertensive patients with diabetes (1988) (3)
- [Echocardiographic analysis of the left ventricle in patients with type II diabetes mellitus]. (1989) (3)
- HYPERINSULINAEMIA AND HYPERTENSION IN DIABETES (1988) (3)
- The Link between Inflammation and Hypertension: Unmasking Mediators. (2021) (3)
- The emerging role of high-density lipoprotein cholesterol in hypertension trials. (2009) (3)
- Low mid‐wall fractional shortening identifies a subgroup of hypertensive patients with increased left ventricular mass and ambulatory blood pressure (1993) (3)
- The Link between Inflammation and Hypertension: Unmasking Mediators. (2021) (3)
- Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies. (2015) (3)
- Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study (2021) (3)
- More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension (2011) (3)
- Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies. (2015) (3)
- Masked and White-Coat Hypertension: Moving to African Americans. (2015) (3)
- Association between decreased nocturnal blood pressure reduction and cardiac hypertrophy in hypertensive women (1991) (3)
- Long-term ketanserin in arterial hypertension (1985) (3)
- Ablation of atrial tachycardia in the setting of prior mitral valve surgery (2021) (3)
- hypertension Circadian blood pressure changes and left ventricular hypertrophy in essential (2011) (3)
- Monday, 27 August 2012 (2012) (3)
- Masked and White-Coat Hypertension: Moving to African Americans. (2015) (3)
- Dipping pattern and short-term blood pressure variability are stronger predictors of cardiovascular events than average 24-hour blood pressure in young hypertensive subjects. (2022) (3)
- Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study (2021) (3)
- Comparative effects on blood pressure of different calcium-blocking agents. (1986) (3)
- Gathering evidence on the prognostic role of central blood pressure in hypertension (2018) (3)
- Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective. (2008) (3)
- PROGNOSTIC VALUE OF AMBULATORY BLOOD PRESSURE MONITORING. AUTHORS' REPLY (1995) (3)
- The emerging role of high-density lipoprotein cholesterol in hypertension trials. (2009) (3)
- Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study (2021) (3)
- RELATIONSHIP BETWEEN DIURETIC RELATED HYPERURICEMIA AND CARDIOVASCULAR EVENTS: DATA FROM THE URRAH (URIC ACID RIGHT FOR HEART HEALTH) STUDY (3)
- 405 Myopericarditis after SARS-CoV-2 MRNA vaccination: casual or causal relationship? (2021) (2)
- BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIAL: 9A.08 (2011) (2)
- Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy (2017) (2)
- Pentraxin-3 and the pathogenesis of preeclampsia (2020) (2)
- Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values (2022) (2)
- High-Sensitivity Cardiac Troponin T and the Diagnosis of Cardiovascular Disease in the Emergency Room: The Importance of Combining Cardiovascular Biomarkers with Clinical Data (2022) (2)
- Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patients (2020) (2)
- Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents (2012) (2)
- Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease. (2019) (2)
- [Atrial fibrillation and sudden cardiac death: a mystery to unravel?] (2021) (2)
- Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level. (2022) (2)
- Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography (2016) (2)
- Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers. (1985) (2)
- The revolution of the anti-diabetic drugs in cardiology (2020) (2)
- What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? (2018) (2)
- OR-64: Circadian rhythm of pulse pressure in hypertension: prognostic implications (2003) (2)
- The Clinical Significance of New-Onset Diabetes Mellitus in Hypertension (2008) (2)
- Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy (2011) (2)
- Response to Morning Surge, Dipping, and Sleep-Time Blood Pressure as Prognostic Markers of Cardiovascular Risk (2013) (2)
- Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation (2019) (2)
- Influence of intravenous β-adrenergic blockade with or without partial agonist activity upon plasma cyclic AMP and catecholamines in healthy subjects (2004) (2)
- Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patients (2020) (2)
- Diagnosis of white-coat hypertension based solely on systolic blood pressure. The Piuma study (2005) (2)
- The Clinical Significance of New-Onset Diabetes Mellitus in Hypertension (2008) (2)
- Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy (2011) (2)
- The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure (2022) (2)
- The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure (2022) (2)
- Metabolic Aspects and Associated Risk Factors VITAMIN D SUPPLEMENTATION AND INCIDENT PREECLAMPSIA : FINDINGS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED CLINICAL STUDIES (2019) (2)
- Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk (2010) (2)
- Echocardiography in clinical pharmacology: developing new concepts on the pathophysiology of left ventricular hypertrophy in arterial hypertension. (1983) (2)
- Diagnosis of white-coat hypertension based solely on systolic blood pressure. The Piuma study (2005) (2)
- O-48: Ambulatory vs clinic blood pressure as a predictor of cardiovascular morbidity incidence* (2001) (2)
- ECHOCARDIOGRAPHY AND SEPTAL THICKNESS (1987) (2)
- Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level. (2022) (2)
- Clinical Significance of the Blood Pressure Changes from Day to Night (2011) (2)
- Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents (2012) (2)
- Mechanisms of Left Ventricular Hypertrophy in Hypertension: More than Just Blood Pressure (2015) (2)
- Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values (2022) (2)
- Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk (2010) (2)
- Day-Night Related Events: Nighttime Blood Pressure Fall and Morning Blood Pressure Rise (2019) (2)
- Good news for beta-blockers in perioperative medicine (2011) (2)
- SAFETY AND EFFICACY OF LOW BLOOD PRESSURE AMONG PATIENTS WITH DIABETES: SUB-GROUP ANALYSES FROM THE ONTARGET TRIAL: 7E.02 (2011) (2)
- Incomplete normalization of left ventricular mass in well-controlled hypertension (1998) (2)
- Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation (2019) (2)
- OR-64: Circadian rhythm of pulse pressure in hypertension: prognostic implications (2003) (2)
- Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale. (1999) (2)
- Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy (2017) (2)
- The revolution of the anti-diabetic drugs in cardiology (2020) (2)
- The heart in arterial hypertension. (1999) (2)
- Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease. (2019) (2)
- Contribution of the ABP-International study to the definition of night-time tachycardia. (2014) (2)
- Role of Adrenergic Overactivity and Pressure Overload in the Pathogenesis of Left Ventricular Hypertrophy in Borderline and Sustained Essential Hypertension in Man (1982) (2)
- [Systolic, diastolic and pulse pressure: prognostic implications]. (2001) (2)
- Good news for beta-blockers in perioperative medicine (2011) (2)
- Response to Morning Surge, Dipping, and Sleep-Time Blood Pressure as Prognostic Markers of Cardiovascular Risk (2013) (2)
- What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? (2018) (2)
- A Fixed Combination of Metoprolol Slow-Release and Chlorthalidone, Given Once Daily, in the Long-Term Treatment of Arterial Hypertension (1982) (2)
- Response to are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument. (2013) (2)
- Good News from Aliskiren (2009) (2)
- Pentraxin-3 and the pathogenesis of preeclampsia (2020) (2)
- Day-Night Related Events: Nighttime Blood Pressure Fall and Morning Blood Pressure Rise (2019) (2)
- Clinical Significance of the Blood Pressure Changes from Day to Night (2011) (2)
- Good News from Aliskiren (2009) (2)
- Prehypertension and Cardiometabolic Syndrome (2019) (2)
- [Atrial fibrillation and sudden cardiac death: a mystery to unravel?] (2021) (2)
- Response to morning surge, dipping, and sleep-time blood pressure as prognostic markers of cardiovascular risk. (2013) (1)
- Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus. (2015) (1)
- Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2 (2023) (1)
- Performance of creatinine- and cystatin C-based formulas to estimate glomerular filtration rate. (2020) (1)
- Ambulatory pulse pressure: A strong prognostic marker in essential hypertension (1998) (1)
- Interpretation of Ambulatory Blood Pressure Profile: A Practical Approach for Clinicians (2013) (1)
- Antihypertensive efficacy of slow-release metoprolol and chlorthalidone as fixed combination: A randomized double blind comparison with chlorthalidone (1983) (1)
- Procedural Feasibility and Long-Term Efficacy of Catheter Ablation of Atypical Atrial Flutters in a Wide Spectrum of Heart Diseases: An Updated Clinical Overview (2022) (1)
- E34 Prognostic value of different electrocardiographic criteria for left ventricular hypertrophy in hypertension (1997) (1)
- Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals (2019) (1)
- [Cardiac failure in hypertensive cardiopathy]. (2000) (1)
- Implications in the assessment of white coat hypertension Variability between current definitions of 'normal' ambulatory blood pressure. (2011) (1)
- Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure Changes (2022) (1)
- WHITE-COAT HYPERTENSION. AUTHORS' REPLY (1996) (1)
- [What are the main novelties in the recent US and European guidelines for the management of hypertension?] (2018) (1)
- Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? (2010) (1)
- Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets (2011) (1)
- Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? (2010) (1)
- Ablation of atrial tachycardia in the setting of prior mitral valve surgery. (2020) (1)
- I5 - Left ventricular hypertrophy in hypertensive smokers (1995) (1)
- [What are the main novelties in the recent US and European guidelines for the management of hypertension?] (2018) (1)
- SERUM URIC ACID, INDEPENDENTLY OF ARTERIAL HYPERTENSION, PREDICTS NON-FATAL INCIDENT CEREBROVASCULAR EVENTS IN AN ITALIAN LARGE COHORT OF MEN AND WOMEN. SEARCH FOR A CUT-OFF VALUE (2019) (1)
- Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals (2019) (1)
- Factors influencing left ventricular hypertrophy in systemic hypertension. (1983) (1)
- Alcohol intake and atrial fibrillation: A new topic in gender medicine. (2020) (1)
- Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key? (2015) (1)
- Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant (2023) (1)
- Emerging therapies in the management of hypertensive patients with osteoarthritis (2011) (1)
- Alcohol intake and atrial fibrillation: A new topic in gender medicine. (2020) (1)
- [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study]. (2000) (1)
- Arrhythmias Involving Variants of Accessory Pathways. (2020) (1)
- Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant (2023) (1)
- Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets (2011) (1)
- Inadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review (2022) (1)
- Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
- Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure Changes (2022) (1)
- Heart rate recovery in adult individuals with asthma. (2022) (1)
- Protein intake in type 1 diabetes: putting controversies into perspectives. (2013) (1)
- Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision Analyses (2016) (1)
- Captopril compared with nifedipine in the treatment of heart failure: a randomized study (1983) (1)
- DOES THE REDUCTION IN SYSTOLIC BLOOD PRESSURE ALONE EXPLAIN THE REGRESSION OF LEFT VENTRICULAR HYPERTROPHY?: S7 (2004) (1)
- Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease (2021) (1)
- Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study (2019) (1)
- EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION (2016) (1)
- Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study (2023) (1)
- Emerging therapies in the management of hypertensive patients with osteoarthritis (2011) (1)
- Cardiac complications of COVID-19 vaccination: now we know more (2022) (1)
- Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation (2019) (1)
- [Noninvasive ambulatory monitoring of arterial pressure in hypertensive patients: inside or outside the hospital?]. (1990) (1)
- [Progress in the treatment of hypertension]. (2021) (1)
- DIPPING PATTERN AND SHORT-TERM BLOOD PRESSURE VARIABILITY ARE STRONGER PREDICTORS OF CARDIOVASCULAR EVENTS THAN AVERAGE 24-HOUR BLOOD PRESSURE IN HYPERTENSION OF THE YOUNG (2021) (1)
- Inadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review (2022) (1)
- Effect of menopause on day-night blood pressure changes and left ventricular function in hypertension (1997) (1)
- Pathophysiology of Atypical Atrial Flutters. (2022) (1)
- Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease (2021) (1)
- [Progress in the treatment of hypertension]. (2021) (1)
- Risk and decision making in patients with hypertension (2014) (1)
- DIPPING PATTERN AND SHORT-TERM BLOOD PRESSURE VARIABILITY ARE STRONGER PREDICTORS OF CARDIOVASCULAR EVENTS THAN AVERAGE 24-HOUR BLOOD PRESSURE IN HYPERTENSION OF THE YOUNG (2021) (1)
- Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline. (1985) (1)
- Evaluation of metropolol cardioselectivity: intensitivity of the bronchial response to exercise in healthy subjects (1984) (1)
- Nifedipine in heart failure (1984) (1)
- Interpretation of Ambulatory Blood Pressure Profile: A Practical Approach for Clinicians (2013) (1)
- Cardiac complications of COVID-19 vaccination: now we know more (2022) (1)
- Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2 (2023) (1)
- Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus. (2015) (1)
- Response to morning surge, dipping, and sleep-time blood pressure as prognostic markers of cardiovascular risk. (2013) (1)
- Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study (2023) (1)
- Diagnosis of White-coat Hypertension Based Solely on Systolic Blood Pressure (2005) (1)
- Impact of type II diabetes and gender on major clinical events after percutaneous coronary intervention. (2020) (1)
- Masked Nocturnal Hypertension:A Complex Phenomenon to Detect in Clinical Practice. (2021) (1)
- EFFECTS OF DABIGATRAN VERSUS WARFARIN IN RELATION TO LEFT VENTRICULAR HYPERTROPHY IN ATRIAL FIBRILLATION (2016) (1)
- Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients. (1983) (1)
- G55 Lack of association between noninvasive blood pressure variability and cardiac hypertrophy in hypertension (1997) (1)
- [The irrelevance of the clinical arterial pressure with respect to outpatient pressure in defining the risk of left ventricular hypertrophy in essential arterial hypertension]. (1991) (1)
- Masked Nocturnal Hypertension:A Complex Phenomenon to Detect in Clinical Practice. (2021) (1)
- Protein intake in type 1 diabetes: putting controversies into perspectives. (2013) (1)
- Ambulatory blood pressure monitoring in mild hypertension. (1995) (1)
- Diagnosis of White-coat Hypertension Based Solely on Systolic Blood Pressure (2005) (1)
- Asymptomatic left ventricular dysfunction: a potent predictor of cardiac complications in hypertension (2004) (0)
- Commentary The SPRINT trial (2015) (0)
- [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension]. (1981) (0)
- Hypertensive left ventricular hypertrophy but not ace-gene polymorphism affects adverse outcomes. (1999) (0)
- contribute to a cumulative blood pressure load which with time may produce end-organ damage. (1996) (0)
- PROGNOSTIC CUTOFF OF TRIGLYCERIDES PREDICTING CARDIOVASCULAR OUTCOME IN A LARGE REGIONAL-BASED ITALIAN DATABASE (2022) (0)
- contribute to a cumulative blood pressure load which with time may produce end-organ damage. (1996) (0)
- The harvest-piuma joint study on white-coat hypertension (WC) (1999) (0)
- [Effects of enalapril on the mass and function of the left ventricle in hypertensive subjects]. (1986) (0)
- [Cardiac protection and antihypertensive therapy: facts and theories]. (1986) (0)
- [The ONTARGET trial]. (2009) (0)
- Therapy of Type 2 diabetes: more gliflozines and less metformin? (2023) (0)
- Abstract 13225: Which Oral Anti-Coagulant Do Patients Prefer for Stroke Prevention in Non-Valvular Atrial Fibrillation? (2016) (0)
- P-393: Prognostic value of different indexizations of left ventricular mass in hypertension (2001) (0)
- , Janice and Stroke in Patients With Coronary Artery Disease Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction (2014) (0)
- Discussion: Contemporary guidelines on implantable cardioverter defibrillator (ICD) therapy do not specifically address recommendations for secondary prevention after life-threatening ventricular arrhythmias due to vasospasm. The arrhythmic risk of coronary vasospasm (2020) (0)
- An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here? (2021) (0)
- [ANMCO Position paper: Direct new oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation: clinical scenarios and future perspectives]. (2016) (0)
- Regression Equations of Systolic and Diastolic Blood Pressure on Age in Nuns and Controls , fry Age Group at Entry Variable Systolic BP Nuns Controls Nuns Controls (2005) (0)
- Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials (2015) (0)
- Theme II: debate: ambulatory blood pressure monitoring should be routine in clinical management Ambulatory blood pressure monitoring should be routine in untreated hypertensive subjects and in those with resistant hypertension. (1999) (0)
- White-coat hypertension. (1997) (0)
- [Dynamic monitoring of blood pressure: population studies]. (1999) (0)
- [Blood pressure: the lower the better? Maybe yes]. (2016) (0)
- Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin? (2023) (0)
- P-260: Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension (2005) (0)
- Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Commentary (2007) (0)
- PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY (2018) (0)
- Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
- ACE inhibitors provoke cough: Offer a sartan drug? (2009) (0)
- Increased arterial stiffness: A major determinant of the white-coat effect (2006) (0)
- Selected Abstracts from XXXVI National Congress of the Italian Society of Hypertension (SIIA), Rome, 26–28 September 2019 (2019) (0)
- Prognostic in Poor Sleepers? Response to Why Is Nondipping in Ambulatory Blood Pressure Monitoring Not (2013) (0)
- P2246Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation (2018) (0)
- Home blood pressure and treatment decisions: caveat emptor. (2016) (0)
- Clinical Medicine : Therapeutics Good news from Aliskiren ? (2009) (0)
- Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET (2008) (0)
- PROGNOSTIC CUT-OFF VALUES OF SERUM URIC ACID ASSOCIATED WITH FATAL AND NON FATAL INCIDENT MYOCARDIAL INFARCTION INDEPENDENTLY OF ARTERIAL HYPERTENSION IN A LARGE COHORT (2019) (0)
- A18644 Echocardiography in Low-Risk Hypertensive Patients. When is it needed? (2018) (0)
- A reviewer critique of microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised? (2006) (0)
- BLOOD PRESSURE AND OTHER DETERMINANTS OF NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS AT HIGH CARDIOVASCULAR RISK: THE ONTARGET/TRANSCEND STUDY: LB1.4 (2011) (0)
- Serial Changes in Left Ventricular Mass in Hypertension: Prognostic Impact (2005) (0)
- [Evaluation of cardiovascular risk and perioperative management of patients undergoing noncardiac surgery. Results of an ANMCO web survey]. (2018) (0)
- OR-7: Regression of left ventricular hypertroiphy and risk of stroke in hypertension (2005) (0)
- Ventricular arrhythmias during long-term chlorthalidone or beta-blocker therapy in hypertensive patients (1987) (0)
- [Ambulatory blood pressure monitoring in clinical practice]. (2008) (0)
- SaO034GLOMERULAR HYPERFILTRATION IS AND INDEPENDENT PREDICTOR OF ADVERSE CARDIOVASCULAR EVENTS (2018) (0)
- Leuven Consensus Conference on Blood Pressure Monitoring. Task Force III: Target organ damage, morbidity and mortality (1999) (0)
- Blunted Nocturnal FallinBloodPressure in Hypertensive Women WithFuture Cardiovascular MorbidEvents (2013) (0)
- Longitudinal Event-Based Studies From Independent Groups Addressing the Prognostic Value of Ambulatory and Home (2009) (0)
- [The STEP trial: how low should we go with blood pressure in hypertensive patients?] (2021) (0)
- Antihypertensive activity at rest and during dynamic exercise of oxprenolol oros 16/260 24 hours after dosing: a double-blind comparison with atenolol (1986) (0)
- Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16 (2023) (0)
- 11.9 Differences between ACE Inhibitor and Angiotensin II Receptor Blocker-based therapy in preventing myocardial infarction, stroke and cardiovascular mortality: a meta-analysis (2008) (0)
- Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease (2012) (0)
- [Sex differences in echocardiographic indices of left ventricular hypertrophy in arterial hypertension. Influence of age and pressure levels over 24 hours]. (1990) (0)
- Chronological age and vascular age staring at each other on the ring of cardiovascular prevention (2021) (0)
- [Doppler echocardiography in atrial myxoma]. (1989) (0)
- Electrocardiography or echocardiography in hypertension (2007) (0)
- 264 Cardiac and pulmonary sequelae after COVID-19 pneumonia: a case series (2021) (0)
- Optimal Use of the Non-Inferiority Trial Design (2020) (0)
- Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention (2021) (0)
- Blood Pressure Measurement/Monitoring (2007) (0)
- E013: Left ventricular mass and prognosis in hypertension: a strong, independent and continuous association (1999) (0)
- Atypical Cases of Typical Atrial Flutter? A Case Study. (2022) (0)
- [Antihypertensive therapy and cardiovascular prevention. The role of angiotensin II receptor blockers]. (2007) (0)
- Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach (2023) (0)
- Different prognostic impact of blood pressure variability on cardiac and cerebrovascular events in hypertension (2004) (0)
- K037 Depressed left ventricular performance in essential hypertension: The role of 24-hour BP (1998) (0)
- Response to Do Extreme Dippers Have a Lower Cardiovascular Risk Than Dippers (2012) (0)
- Parallelism between cardiac and vascular changes at different sites in the early phase of hypertension (1999) (0)
- Response to Body Position and Quality of Sleep Interfere With Day-Night Blood Pressure Dip (2012) (0)
- S-14-3: WHICH IS THE OPTIMAL BP TARGET TO ACHIEVE? SHOULD GUIDELINES BE UPDATED? (2023) (0)
- ages Reducing blood pressure in people of different (2008) (0)
- [A trans-mitral Doppler echocardiographic study in arterial hypertension]. (1990) (0)
- 24-hour blood pressure monitoring: its efficacy and techniques (2011) (0)
- P-260: Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension (2005) (0)
- New Approach in the Prevention of Atrial Fibrillation: Role of Angiotensin II Antagonists (2005) (0)
- [Blood pressure goal for hypertension in the elderly]. (2023) (0)
- [Obesity and hypertension]. (2008) (0)
- Endothelial dysfunction is an independent predictor of left ventricular hypertrophy in untreated hypertension (1999) (0)
- Role of Ambulatory Blood Pressure Monitoring in Prehypertension (2018) (0)
- Prognostic value of “high normal” serum creatinine in patients with essential hypertension (2000) (0)
- Consensus Document European Society of Hypertension practice guidelines for ambulatory blood pressuremonitoring (2014) (0)
- Risk Stratification Models to Predict Hypertensive Disorders of Pregnancy: Additive Value of Standard Electrocardiography (2017) (0)
- Heart Rate Recovery in Adult Individuals with Asthma (2021) (0)
- Average Effects of New Oral Anticoagulants Versus Warfarin. (2014) (0)
- 512 Long-term survival in patients with post-operative atrial fibrillation after cardiac surgery: analysis from a prospective-cohort study (2021) (0)
- Hypertensive Heart Disease (2018) (0)
- Response to Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring (2009) (0)
- [Waiting for the new oral anticoagulants: questions and answers about dabigatran]. (2013) (0)
- [Impact of the COVID-19 pandemic on cardiological clinical trials]. (2022) (0)
- Transient coronary artery occlusion during coronary sinus lead extraction: a possible cause of ischaemia and hypotension. (2020) (0)
- 9.3 Effects of Barnidipine on Ambulatory Blood Pressure in Hypertensive Subjects with Metabolic Syndrome (2007) (0)
- ABPM in the prognostic evaluation og hypertension patients (2004) (0)
- Ambulatory Blood Pressure Measurement Home Blood Pressure Measurements Will or Will Not Replace 24-Hour (2009) (0)
- Antihypertensive and biochemical effects of etozoline: a double-blind study using ambulatory blood pressure monitoring (1988) (0)
- How Low Should We Go With Home Blood Pressure in Elderly Patients With Atrial Fibrillation? (2022) (0)
- ACE-Inhibitors in High Vascular Risk: From Experimental Medicine toClinical Trials (2013) (0)
- Response by Verdecchia et al to Letter Regarding Article "Sudden Cardiac Death in Hypertensive Patients". (2019) (0)
- Blood pressure lowering in th e oldest old (2010) (0)
- CARDIAC HYPERTROPHY IN OLD AGE (1989) (0)
- Use of Antibiotics and Mortality in Women: Does Duration of Exposure Matter? (2020) (0)
- The view on arterial hypertension (2010) (0)
- Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky (2012) (0)
- Cardiovascular effects of tight versus usual blood-pressure control – Authors' reply (2009) (0)
- Collaborative Care for the Identification of Pregnant Women at High Risk for the Development of Hypertensive Disorders (2012) (0)
- Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity. (2011) (0)
- Calcium antagonists and cardiovascular risk in patients with essential hypertension and non-insulin-dependent diabetes (1999) (0)
- mRNA Metabolism and Hypertension (2023) (0)
- What is new in the management of arterial hypertension after the recent European and North American guidelines (2018) (0)
- SERUM URIC ACID, LEFT VENTRICULAR MASS AND CARDIOVASCULAR DEATH. THE URIC ACID RIGHT FOR HEART HEALTH (URRAH) STUDY (2022) (0)
- P-75: Risk of stroke in white-coat hypertension: a multinational registry (2003) (0)
- 512 Long-termsurvivalinpatientswithpost-operativeatrialfibrillationafter cardiacsurgery:analysisfromaprospective-cohortstudy (2021) (0)
- [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris]. (1993) (0)
- Obituary (2017) (0)
- Metabolic consequences of salbutamol poisoning reversed by propranolol. (1982) (0)
- [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects]. (1982) (0)
- [Pulse pressure and mean pressure: physiopathology and predictive value of coronary events and ictus]. (2001) (0)
- Abstracts from 2020 national congress of the Italian Society of Hypertension (SIIA) (2020) (0)
- Antihypertensive Drugs and Coronary Artery Disease (2005) (0)
- P-261 AN A 1166 C POLYMORPHISM OF THE ANGIOTENSIN II AT 1 RECEPTOR GENE DOES NOT INFLUENCE THE DIAGNOSIS OF ARTERIAL HYPERTENSION DURING 7 YEARS FOLLOW UP (2002) (0)
- [Individual pressure profile in clinical practice]. (1999) (0)
- Should we rethink the blood pressure targets in hypertension guidelines? (2022) (0)
- Improved Performance of Traditional ECG for Diagnosis of Left Ventricular Hypertrophy in Hypertension: 2.11 (2005) (0)
- Spontaneous evolution of white-coat hypertension. (1996) (0)
- How important is to reduce sodium and increase potassium in patients with hypertension? (2017) (0)
- Mapping and Ablation of Atypical Atrial Flutters. (2022) (0)
- Sleep insomnia pattern and COVID-19: a snapshot of in-hospital patients (2021) (0)
- C074: Adverse prognostic significance of a blunted circadian rhythm of heart rate in essential hypertension (1998) (0)
- Response to Why Is Nondipping In Ambulatory Blood Pressure Monitoring Not Prognostic in Poor Sleepers (2007) (0)
- Blood pressure analyses from 25 595 patients (from 25 620 randomised) during the ONTARGET trial: reflections on current guidelines (2008) (0)
- African Ancestry and Uncontrolled Hypertension: Current Knowledge and Future Perspectives. (2021) (0)
- [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?]. (2007) (0)
- [OP.3A.01] GLOMERULAR HYPERFILTRATION. A PREDICTOR OF ADVERSE CARDIOVASCULAR OUTCOME (2017) (0)
- A029: Midwall shortening fraction, left ventricular mass and prognosis in essential hypertension (2000) (0)
- Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort (2015) (0)
- [Arterial hypertension: an update]. (2010) (0)
- [Should antihypertensive therapy be administered at morning or evening? The TIME study]. (2023) (0)
- A fixed combination of low-dose oxprenolol, chlorthalidone and hydralazine in the treatment of arterial hypertension: a controlled study (1983) (0)
- Aggressive blood pressure reduction in patients at high vascular risk: is it dangerous? (2012) (0)
- White-Coat Hypertension: State of the Art (2000) (0)
- Aggressive blood pressure reduction in patients at high vascular risk: is it dangerous? (2012) (0)
- [Arterial hypertension: an update]. (2010) (0)
- [Should antihypertensive therapy be administered at morning or evening? The TIME study]. (2023) (0)
- Highlight from International Congress (2006) (0)
- IN OCTOGENARIANS EXTREME DIPPING CARRIES THE SAME RISK OF CARDIOVASCULAR EVENTS AS REVERSE DIPPING. AN INSIGHT FROM THE ABP-INTERNATIONAL STUDY (2019) (0)
- Prognostic impact of a gender-ambulatory blood pressure interaction in 10 cohorts of 17,312 patients diagnosed with hypertension: systematic review and meta-analysis (2014) (0)
- SaO034 GLOMERULAR HYPERFILTRATION IS AND INDEPENDENT PREDICTOR OF ADVERSE CARDIOVASCULAR EVENTS (2018) (0)
- Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
- [Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation]. (2017) (0)
- [Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?]. (2007) (0)
- [Indications for echocardiography in subjects with essential arterial hypertension]. (2000) (0)
- How important is to reduce sodium and increase potassium in patients with hypertension? (2017) (0)
- African Ancestry and Uncontrolled Hypertension: Current Knowledge and Future Perspectives. (2021) (0)
- Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure. (1983) (0)
- [An unusual case of Takotsubo syndrome after dipyridamole stress echocardiography]. (2019) (0)
- Response to Why Is Nondipping In Ambulatory Blood Pressure Monitoring Not Prognostic in Poor Sleepers (2007) (0)
- Antihypertensive Drugs and Coronary Artery Disease (2005) (0)
- Problems of homogeneity in multicentre trials in hypertension using non-invasive ambulatory blood pressure monitoring (1992) (0)
- P-75: Risk of stroke in white-coat hypertension: a multinational registry (2003) (0)
- 512 Long-termsurvivalinpatientswithpost-operativeatrialfibrillationafter cardiacsurgery:analysisfromaprospective-cohortstudy (2021) (0)
- P-261 AN A 1166 C POLYMORPHISM OF THE ANGIOTENSIN II AT 1 RECEPTOR GENE DOES NOT INFLUENCE THE DIAGNOSIS OF ARTERIAL HYPERTENSION DURING 7 YEARS FOLLOW UP (2002) (0)
- [Analysis of pre-hospitalization time in coronary disease in a provincial hospital]. (1981) (0)
- Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity. (2011) (0)
- Use of Antibiotics and Mortality in Women: Does Duration of Exposure Matter? (2020) (0)
- Improved Performance of Traditional ECG for Diagnosis of Left Ventricular Hypertrophy in Hypertension: 2.11 (2005) (0)
- Should we rethink the blood pressure targets in hypertension guidelines? (2022) (0)
- P6285Predictors of major bleeding in patients aged 90 years or over with atrial fibrillation on anticoagulant treatment (2018) (0)
- The Renin-Angiotensin System in Cardiovascular and Renal Disease (2012) (0)
- The view on arterial hypertension (2010) (0)
- Hypertensive Heart Disease (2018) (0)
- 512 Long-term survival in patients with post-operative atrial fibrillation after cardiac surgery: analysis from a prospective-cohort study (2021) (0)
- Response to Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring (2009) (0)
- Response by Verdecchia et al to Letter Regarding Article "Sudden Cardiac Death in Hypertensive Patients". (2019) (0)
- ABPM in the prognostic evaluation og hypertension patients (2004) (0)
- 845 THE PREDICTIVE ROLE OF HIGH-SENSITIVITY CARDIAC TROPONIN T IN THE EMERGENCY ROOM: COMBINING BIOMARKERS WITH CLINICAL DATA LEADS TO THE DIAGNOSIS OF CARDIOVASCULAR DISEASE (2022) (0)
- What is new in the management of arterial hypertension after the recent European and North American guidelines (2018) (0)
- Prognostic value of ambulatory blood pressure monitoring. (1995) (0)
- Average Effects of New Oral Anticoagulants Versus Warfarin. (2014) (0)
- [Hemodynamic and humoral changes in long-distance athletes]. (1983) (0)
- mRNA Metabolism and Hypertension (2023) (0)
- [Blood pressure goal for hypertension in the elderly]. (2023) (0)
- Role of Ambulatory Blood Pressure Monitoring in Prehypertension (2018) (0)
- New Approach in the Prevention of Atrial Fibrillation: Role of Angiotensin II Antagonists (2005) (0)
- Collaborative Care for the Identification of Pregnant Women at High Risk for the Development of Hypertensive Disorders (2012) (0)
- Cardiovascular effects of tight versus usual blood-pressure control – Authors' reply (2009) (0)
- S-14-3: WHICH IS THE OPTIMAL BP TARGET TO ACHIEVE? SHOULD GUIDELINES BE UPDATED? (2023) (0)
- Ablation of Accessory Pathways with Challenging Anatomy. (2020) (0)
- Response to Do Extreme Dippers Have a Lower Cardiovascular Risk Than Dippers (2012) (0)
- P4621Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort (2017) (0)
- Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The ‘Ambulatory Does Prediction Valid (ADPV)’ Approach (2023) (0)
- Circulating insulin and insulin-growth-factor-1 are independent determinants of LV mass and geometry in hypertension. (1999) (0)
- P1187Pocket-Hematoma after cardiac implantable electronic devices surgery: a single centre study (2020) (0)
- Blood pressure lowering in th e oldest old (2010) (0)
- Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky (2012) (0)
- Paolo Verdecchia Implications Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical (2000) (0)
- O-7: Prognostic impact of ambulatory blood pressure control in treated hypertensive patients (2001) (0)
- Atrial fibrillation recurrence after transcatheter ablation worsens left atrial strain (2020) (0)
- Ambulatory Blood Pressure Measurement Home Blood Pressure Measurements Will or Will Not Replace 24-Hour (2009) (0)
- Hyperinsulinemia is associated with a blunted diurnal rhythm of blood pressure in non-diabetic subjects with essential hypertension (1999) (0)
- 9.3 Effects of Barnidipine on Ambulatory Blood Pressure in Hypertensive Subjects with Metabolic Syndrome (2007) (0)
- Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease (2012) (0)
- Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16 (2023) (0)
- [The POISE study]. (2008) (0)
- Longitudinal Event-Based Studies From Independent Groups Addressing the Prognostic Value of Ambulatory and Home (2009) (0)
- How Low Should We Go With Home Blood Pressure in Elderly Patients With Atrial Fibrillation? (2022) (0)
- [The STEP trial: how low should we go with blood pressure in hypertensive patients?] (2021) (0)
- ACE-Inhibitors in High Vascular Risk: From Experimental Medicine toClinical Trials (2013) (0)
- [Regression of left ventricular hypertrophy by a prolonged anti-hypertensive treatment]. (1982) (0)
- [Ambulatory blood pressure monitoring in clinical practice]. (2008) (0)
- Acknowledgement to Referees (2014) (0)
- FP118RENAL FUNCTION IS RELATED TO INCREASED THROMBOEMBOLIC AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION IN A REAL-WORLD SETTING: THE UMBRIA-FA STUDY (2018) (0)
- [Peri-myocarditis during urinary tract infection by Escherichia coli]. (2020) (0)
- A18644 Echocardiography in Low-Risk Hypertensive Patients. When is it needed? (2018) (0)
- Risk Stratification Models to Predict Hypertensive Disorders of Pregnancy: Additive Value of Standard Electrocardiography (2017) (0)
- Home blood pressure and treatment decisions: caveat emptor. (2016) (0)
- Efficacy and sustainability of 24-h blood pressure control: focus on olmesartan-driven products (2011) (0)
- Highlights from International Congress (2007) (0)
- 2009 SIPREC Consensus Document — Executive Summary (2010) (0)
- Response to Body Position and Quality of Sleep Interfere With Day-Night Blood Pressure Dip (2012) (0)
- Prognostic in Poor Sleepers? Response to Why Is Nondipping in Ambulatory Blood Pressure Monitoring Not (2013) (0)
- Antihypertensive activity of indapamide at rest and during isometric exercise (1985) (0)
- SERUM URIC ACID, INDEPENDENTLY OF ARTERIAL HYPERTENSION, PREDICTS FATAL HEART FAILURE IN A LARGE COHORT OF MEN AND WOMEN. SEARCH FOR A CUT-OFF VALUE (2019) (0)
- PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY (2018) (0)
- ACE inhibitors provoke cough: Offer a sartan drug? (2009) (0)
- Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Commentary (2007) (0)
- [Antihypertensive therapy and cardiovascular prevention. The role of angiotensin II receptor blockers]. (2007) (0)
- Different prognostic impact of blood pressure variability on cardiac and cerebrovascular events in hypertension (2004) (0)
- Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention (2021) (0)
- Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin? (2023) (0)
- [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review]. (1982) (0)
- Blood Pressure Measurement/Monitoring (2007) (0)
- [Blood pressure: the lower the better? Maybe yes]. (2016) (0)
- Electrocardiography or echocardiography in hypertension (2007) (0)
- Optimal Use of the Non-Inferiority Trial Design (2020) (0)
- , Janice and Stroke in Patients With Coronary Artery Disease Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction (2014) (0)
- High prevalence of septal thickness overestimation in hypertensive subjects and controls. (1987) (0)
- [Exercise tolerance in angina patients 3 and 24 hours after administration of a new delayed-action preparation of metoprolol]. (1981) (0)
- 264 Cardiac and pulmonary sequelae after COVID-19 pneumonia: a case series (2021) (0)
- Therapy of Type 2 diabetes: more gliflozines and less metformin? (2023) (0)
- [OP.5C.06] MASKED TACHYCARDIA PREDICTS ADVERSE OUTCOME IN HYPERTENSION. THE ABP-INTERNATIONAL STUDY (2016) (0)
- 11.9 Differences between ACE Inhibitor and Angiotensin II Receptor Blocker-based therapy in preventing myocardial infarction, stroke and cardiovascular mortality: a meta-analysis (2008) (0)
- Asymptomatic left ventricular dysfunction: a potent predictor of cardiac complications in hypertension (2004) (0)
- Commentary The SPRINT trial (2015) (0)
- Research Article Prognostic value of circadian blood pressure changes in relation to differing measures of day and night (2008) (0)
- Real-World Evidence on Clinical use of a Novel Oral Anticoagulant for the Treatment of Atrial Fibrillation (2017) (0)
- OR-7: Regression of left ventricular hypertroiphy and risk of stroke in hypertension (2005) (0)
- 404 Acute coronary syndromes after healing from COVID-19: report of the initial observation (2021) (0)
- Serial Changes in Left Ventricular Mass in Hypertension: Prognostic Impact (2005) (0)
- Increased arterial stiffness: A major determinant of the white-coat effect (2006) (0)
- An update on antithrombotic therapy in atrial fibrillation patients in long-term ambulatory setting after percutaneous coronary intervention: where do we go from here? (2021) (0)
- [Long duration of action of metoprolol in the prolonged treatment of angina of effort]. (1981) (0)
- Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET (2008) (0)
- Research Article Prognostic value of circadian blood pressure changes in relation to differing measures of day and night (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paolo Verdecchia?
Paolo Verdecchia is affiliated with the following schools:
